Cushman & Wakefield Ltd. (CWK) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 1, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CWK SEC filings page.
Cushman & Wakefield Ltd. (CWK) reported $10.8B in revenue over the twelve months to Jun 30, 2026, up 11.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cash conversion and deleveraging improved as operating profitability recovered, while reported net earnings remained comparatively thin.
In FY2025, free cash flow reached$293M against$88M of net income, while operating cash flow reached$340M ; accounting earnings therefore understated the cash produced, although the statements do not identify whether noncash items or working-capital movements drove the gap. This cash generation occurred alongside a debt-to-equity ratio falling from 2.2x in FY2021 to 1.3x, showing that internally generated cash has coincided with a less debt-dependent balance sheet.
The business experienced a profitability trough in FY2023, when operating margin fell to
Capital needs remain modest relative to cash generation: FY2025 capital expenditures were
Financial Health Signals
Scored against REITs for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Cushman & Wakefield Ltd.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
FFO Margin measures funds from operations against revenue, and funds from operations is net income with property depreciation added back, since a building written down a little further every year on paper is often worth more rather than less. Cushman & Wakefield Ltd. scores 21/100 on it among other REITs.
FFO Growth follows the three-year path of funds from operations, which is net income with property depreciation added back. Cushman & Wakefield Ltd. scores 83/100 on it among other REITs.
Cushman & Wakefield Ltd.'s net debt of $1.8B, being $2.6B of long-term debt less $784.2M of cash, came to 3.31 times its EBITDA in fiscal year 2025. REITs are ranked here on that debt against their EBITDA, where a lower multiple is the safer one, and Cushman & Wakefield Ltd. scores 69/100 among other REITs.
Cushman & Wakefield Ltd.'s operating income of $452.5M covered its interest expense of $216.2M 2.09 times over in fiscal year 2025. The interest coverage axis ranks REITs on operating income against interest owed, and Cushman & Wakefield Ltd. scores 60/100 among other REITs.
AFFO Margin takes funds from operations, subtracts the spending a REIT needs just to keep its properties in working order, and measures what is left against revenue. Cushman & Wakefield Ltd. scores 27/100 on it among other REITs.
Not available for Cushman & Wakefield Ltd., and counted as zero in the overall score.
Cushman & Wakefield Ltd. scores 1.71, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Cushman & Wakefield Ltd. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Cushman & Wakefield Ltd. generates $3.86 in operating cash flow ($340.4M OCF vs $88.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Cushman & Wakefield Ltd. earns $2.09 in operating income for every $1 of interest expense ($452.5M vs $216.2M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Cushman & Wakefield Ltd. generated $2.8B in revenue in Q2 2026. This represents an increase of 11.2% from the same quarter a year earlier. Against the prior quarter it is up 8.9%.
Cushman & Wakefield Ltd.'s EBITDA was $162.7M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 9.2% from the same quarter a year earlier. Against the prior quarter it is up 93.7%.
Cushman & Wakefield Ltd. reported $52.7M in net income in Q2 2026. This represents a decrease of 8.0% from the same quarter a year earlier. Against the prior quarter it is up 518.3%.
Cushman & Wakefield Ltd. earned $0.22 per diluted share (EPS) in Q2 2026. This represents a decrease of 12.0% from the same quarter a year earlier. Against the prior quarter it is up 540.0%.
Cash & Balance Sheet
Cushman & Wakefield Ltd. generated $45.5M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 15066.7% from the same quarter a year earlier. Against the prior quarter it is up 117.8%.
Cushman & Wakefield Ltd. held $500.5M in cash against $2.4B in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Cushman & Wakefield Ltd.'s gross margin was 18.5% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.9 percentage points.
Cushman & Wakefield Ltd.'s operating margin was 4.9% in Q2 2026, reflecting core business profitability. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.5 percentage points.
Cushman & Wakefield Ltd.'s net profit margin was 1.9% in Q2 2026, showing the share of revenue converted to profit. This is down 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.4 percentage points.
Cushman & Wakefield Ltd.'s ROE was 2.6% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.3 percentage points.
Capital Allocation
Cushman & Wakefield Ltd. invested $8.5M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 8.6% from the same quarter a year earlier. Against the prior quarter it is down 30.3%.
Not reported for Q2 2026.
Not reported for Q2 2026.
CWK Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8B+11.2% | $2.5B+11.0% | $2.9B+10.8% | $2.6B+11.2% | $2.5B+8.6% | $2.3B+4.6% | $2.6B+3.0% | $2.3B+2.5% |
| Cost of Revenue | $2.3B+11.6% | $2.1B+11.3% | $2.3B+11.3% | $2.2B+12.6% | $2.0B+7.6% | $1.9B+3.7% | $2.1B+1.3% | $1.9B+1.6% |
| Gross Profit | $512.0M+9.6% | $420.7M+9.5% | $574.5M+8.7% | $453.9M+5.0% | $467.3M+13.1% | $384.3M+9.1% | $528.4M+10.4% | $432.4M+7.1% |
| SG&A Expenses | $349.3M+9.7% | $336.7M+10.1% | $372.5M+16.5% | $320.6M+2.0% | $318.3M+8.2% | $305.8M+3.3% | $319.7M+0.8% | $314.2M+4.4% |
| Operating Income | $134.2M+9.3% | $58.7M+29.6% | $176.9M+1.4% | $107.5M+43.0% | $122.8M+74.4% | $45.3M+141.0% | $174.5M+58.6% | $75.2M+30.6% |
| EBITDA | $162.7M+9.2% | $84.0M+16.7% | $202.4M-0.8% | $133.3M+28.0% | $149.0M+46.7% | $72.0M+40.4% | $204.1M+39.0% | $104.1M+11.0% |
| Interest Expense | $59.6M+12.0% | $49.2M-5.9% | $54.7M-1.4% | $56.0M+2.0% | $53.2M-12.5% | $52.3M-10.9% | $55.5M-2.5% | $54.9M-38.7% |
| Income Tax | $24.6M+30.2% | $3.0M-3.2% | $10.3M-46.4% | -$6.3M-132.6% | $18.9M+410.8% | $3.1M+34.8% | $19.2M+6300.0% | $19.3M+16.3% |
| Net Income | $52.7M-8.0% | -$12.6M-763.2% | -$22.4M-119.8% | $51.4M+52.5% | $57.3M+324.4% | $1.9M+106.6% | $112.9M+61.7% | $33.7M+199.4% |
| EPS (Basic) | $0.22-12.0% | -$0.05-600.0% | -$0.10-120.4% | $0.22+46.7% | $0.25+316.7% | $0.01+107.7% | $0.49+63.3% | $0.15+200.0% |
| EPS (Diluted) | $0.22-12.0% | -$0.05-600.0% | -$0.09-118.8% | $0.22+57.1% | $0.25+316.7% | $0.01+107.7% | $0.48+60.0% | $0.14+193.3% |
| Diluted Shares (Avg) | 236M+1.7% | 233M+0.2% | N/A | 236M+1.1% | 232M+0.4% | 232M+1.9% | N/A | 233M+2.7% |
Not reported in any period shown, so not listed: R&D Expenses.
CWK Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.6B0.0% | $7.6B+3.2% | $7.7B+1.7% | $7.7B+2.1% | $7.6B+2.9% | $7.4B-1.1% | $7.5B-2.9% | $7.5B-0.6% |
| Current Assets | $2.6B-0.4% | $2.7B+5.5% | $2.8B+5.7% | $2.7B+0.9% | $2.6B+1.7% | $2.6B+5.9% | $2.7B-4.0% | $2.6B+1.2% |
| Cash & Equivalents | $500.5M-19.0% | $600.6M-3.6% | $784.2M-1.1% | $634.4M-18.2% | $618.2M+9.0% | $623.2M+12.6% | $793.3M+3.3% | $775.4M+31.8% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $2.1B-0.1% | $2.1B+1.9% | $2.1B+3.0% | $2.1B+0.3% | $2.1B+1.8% | $2.0B-2.1% | $2.0B-4.0% | $2.0B-0.1% |
| Total Liabilities | $5.5B-2.1% | $5.7B+1.2% | $5.7B-1.3% | $5.7B-1.7% | $5.7B-0.9% | $5.6B-4.0% | $5.8B-5.0% | $5.8B-3.0% |
| Current Liabilities | $2.4B+4.8% | $2.4B+10.1% | $2.6B+11.2% | $2.5B+11.8% | $2.3B+8.9% | $2.2B+1.1% | $2.3B-2.8% | $2.2B+1.1% |
| Non-Current Liabilities | $3.1B-6.9% | $3.3B-4.6% | $3.1B-9.7% | $3.2B-10.1% | $3.3B-6.8% | $3.4B-7.0% | $3.5B-6.4% | $3.6B-5.4% |
| Long-Term Debt | $2.4B-14.4% | $2.6B-9.9% | $2.6B-10.7% | $2.7B-9.2% | $2.8B-6.0% | $2.9B-5.1% | $2.9B-5.1% | $3.0B-4.1% |
| Total Equity | $2.0B+6.2% | $2.0B+9.9% | $2.0B+11.4% | $2.0B+15.0% | $1.9B+16.1% | $1.8B+9.3% | $1.8B+4.6% | $1.7B+8.4% |
| Retained Earnings | -$857.6M+7.5% | -$910.3M+7.5% | -$897.7M+8.9% | -$875.3M+20.3% | -$926.7M+18.2% | -$984.0M+14.1% | -$985.9M+11.8% | -$1.1B+7.4% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable.
CWK Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $54.0M+462.5% | -$243.5M-50.3% | $257.3M+123.4% | $235.5M+20.1% | $9.6M-56.0% | -$162.0M-29.5% | $115.2M-43.1% | $196.1M+4.3% |
| Depreciation & Amortization | $28.5M+8.8% | $25.3M-5.2% | $25.5M-13.9% | $25.8M-10.7% | $26.2M-16.0% | $26.7M-17.8% | $29.6M-19.6% | $28.9M-20.2% |
| Stock-Based Compensation | N/A | $16.3M+1.9% | N/A | N/A | N/A | $16.0M+150.0% | N/A | N/A |
| Capital Expenditures | $8.5M-8.6% | $12.2M+165.2% | $23.0M+147.3% | $10.5M+11.7% | $9.3M-21.2% | $4.6M-56.2% | $9.3M-42.6% | $9.4M-33.8% |
| Free Cash Flow | $45.5M+15066.7% | -$255.7M-53.5% | $234.3M+121.2% | $225.0M+20.5% | $300K-97.0% | -$166.6M-22.9% | $105.9M-43.1% | $186.7M+7.4% |
| Investing Cash Flow | -$35.9M-441.9% | $94.1M+356.8% | $7.9M+123.9% | -$60.1M-204.7% | $10.5M-84.5% | $20.6M+290.7% | -$33.1M-5.8% | $57.4M+188.0% |
| Financing Cash Flow | -$116.1M-219.8% | -$28.1M+32.0% | -$117.4M-110.0% | -$155.5M-172.8% | -$36.3M+46.3% | -$41.3M+43.3% | -$55.9M-308.0% | -$57.0M-9.4% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
CWK Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 18.5%-0.3pp | 16.6%-0.2pp | 19.7%-0.4pp | 17.4%-1.0pp | 18.8%+0.7pp | 16.8%+0.7pp | 20.1%+1.4pp | 18.4%+0.8pp |
| Operating Margin | 4.9%-0.1pp | 2.3%+0.3pp | 6.1%-0.6pp | 4.1%+0.9pp | 4.9%+1.9pp | 2.0%+1.1pp | 6.6%+2.3pp | 3.2%+0.7pp |
| Net Margin | 1.9%-0.4pp | -0.5%-0.6pp | -0.8%-5.1pp | 2.0%+0.5pp | 2.3%+1.7pp | 0.1%+1.4pp | 4.3%+1.6pp | 1.4%+2.9pp |
| Return on Equity | 2.6%-0.4pp | -0.7%-0.8pp | -1.1%-7.6pp | 2.6%+0.6pp | 3.0%+2.2pp | 0.1%+1.9pp | 6.4%+2.3pp | 2.0%+4.1pp |
| Return on Assets | 0.7%-0.1pp | -0.2%-0.2pp | -0.3%-1.8pp | 0.7%+0.2pp | 0.8%+0.6pp | 0.0%+0.4pp | 1.5%+0.6pp | 0.4%+0.9pp |
| Current Ratio | 1.08-0.1x | 1.130.0x | 1.10-0.1x | 1.07-0.1x | 1.13-0.1x | 1.18+0.1x | 1.150.0x | 1.180.0x |
| Debt-to-Equity | 1.19-0.3x | 1.34-0.3x | 1.34-0.3x | 1.39-0.4x | 1.48-0.3x | 1.64-0.2x | 1.68-0.2x | 1.76-0.2x |
| Asset Turnover | 0.370.0x | 0.330.0x | 0.380.0x | 0.340.0x | 0.330.0x | 0.310.0x | 0.350.0x | 0.310.0x |
| FCF Margin | 1.7%+1.6pp | -10.1%-2.8pp | 8.0%+4.0pp | 8.6%+0.7pp | 0.0%-0.4pp | -7.3%-1.1pp | 4.0%-3.3pp | 8.0%+0.4pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Cushman & Wakefield Ltd. CWK | FY2025 | $10.3B | $88.2M | 0.9% | $2.8B | 43/100 |
| Newmark Group, Inc. NMRK | FY2025 | $3.3B | $126.2M | 3.8% | $2.2B | 54/100 |
| Compass, Inc. COMP | FY2025 | $7.0B | -$58.5M | -0.8% | $6.8B | 25/100 |
| IHS Holding Limited IHS | FY2025 | $1.6B | $126.8M | 8.0% | $2.8B | 0/100 |
| FirstService Corporation FSV | FY2025 | $5.5B | $190.7M | 3.5% | $5.6B | 67/100 |
| Colliers International Group Inc. CIGI | FY2025 | $5.6B | $224.6M | 4.0% | $4.6B | 68/100 |
Where Cushman & Wakefield Ltd. Ranks
Frequently Asked Questions
What is Cushman & Wakefield Ltd.'s annual revenue?
Cushman & Wakefield Ltd. (CWK) reported $10.3B in total revenue for fiscal year 2025. This represents a 8.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Cushman & Wakefield Ltd.'s revenue growing?
Cushman & Wakefield Ltd. (CWK) revenue grew by 8.9% year-over-year, from $9.4B to $10.3B in fiscal year 2025.
Is Cushman & Wakefield Ltd. profitable?
Yes, Cushman & Wakefield Ltd. (CWK) reported a net income of $88.2M in fiscal year 2025, with a net profit margin of 0.9%.
What is Cushman & Wakefield Ltd.'s EBITDA?
Cushman & Wakefield Ltd. (CWK) had EBITDA of $556.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Cushman & Wakefield Ltd. have?
As of fiscal year 2025, Cushman & Wakefield Ltd. (CWK) had $784.2M in cash and equivalents against $2.6B in long-term debt.
What is Cushman & Wakefield Ltd.'s gross margin?
Cushman & Wakefield Ltd. (CWK) had a gross margin of 18.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Cushman & Wakefield Ltd.'s operating margin?
Cushman & Wakefield Ltd. (CWK) had an operating margin of 4.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Cushman & Wakefield Ltd.'s net profit margin?
Cushman & Wakefield Ltd. (CWK) had a net profit margin of 0.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Cushman & Wakefield Ltd.'s return on equity (ROE)?
Cushman & Wakefield Ltd. (CWK) has a return on equity of 4.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Cushman & Wakefield Ltd.'s free cash flow?
Cushman & Wakefield Ltd. (CWK) generated $293.0M in free cash flow during fiscal year 2025. This represents a 75.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Cushman & Wakefield Ltd.'s operating cash flow?
Cushman & Wakefield Ltd. (CWK) generated $340.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Cushman & Wakefield Ltd.'s total assets?
Cushman & Wakefield Ltd. (CWK) had $7.7B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Cushman & Wakefield Ltd.'s capital expenditures?
Cushman & Wakefield Ltd. (CWK) invested $47.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Cushman & Wakefield Ltd.'s current ratio?
Cushman & Wakefield Ltd. (CWK) had a current ratio of 1.10 as of fiscal year 2025, which is considered adequate.
What is Cushman & Wakefield Ltd.'s debt-to-equity ratio?
Cushman & Wakefield Ltd. (CWK) had a debt-to-equity ratio of 1.34 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Cushman & Wakefield Ltd.'s return on assets (ROA)?
Cushman & Wakefield Ltd. (CWK) had a return on assets of 1.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Cushman & Wakefield Ltd.'s P/E ratio?
Cushman & Wakefield Ltd. (CWK) trades at 41.0x earnings, its market capitalization divided by net income of $69.1M net income, trailing 12 months to June 30, 2026. The market capitalization is $2.8B as of Oct 1, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Cushman & Wakefield Ltd.'s price-to-sales ratio?
Cushman & Wakefield Ltd. (CWK) trades at 0.3x sales, its market capitalization divided by revenue of $10.8B revenue, trailing 12 months to June 30, 2026. The market capitalization is $2.8B as of Oct 1, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Cushman & Wakefield Ltd.'s Altman Z-Score?
Cushman & Wakefield Ltd. (CWK) has an Altman Z-Score of 1.71, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Cushman & Wakefield Ltd.'s Piotroski F-Score?
Cushman & Wakefield Ltd. (CWK) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Cushman & Wakefield Ltd.'s earnings high quality?
Cushman & Wakefield Ltd. (CWK) has an earnings quality ratio of 3.86x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Cushman & Wakefield Ltd. cover its interest payments?
Cushman & Wakefield Ltd. (CWK) has an interest coverage ratio of 2.09x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Cushman & Wakefield Ltd.?
Cushman & Wakefield Ltd. (CWK) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its REITs peer group. The score is a 0-100 composite of six dimensions (FFO Margin, FFO Growth, Leverage, Interest Cov., AFFO Margin, Dividend Cov.), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.